X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Orchid Chemicals with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs PANACEA BIOTECH - Comparison Results

ORCHID PHARMA LTD    Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD PANACEA BIOTECH ORCHID PHARMA LTD/
PANACEA BIOTECH
 
P/E (TTM) x -0.2 -6.9 - View Chart
P/BV x 0.1 2.2 6.4% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ORCHID PHARMA LTD   PANACEA BIOTECH
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
PANACEA BIOTECH
Mar-14
ORCHID PHARMA LTD/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs194149 130.5%   
Low Rs3582 42.5%   
Sales per share (Unadj.) Rs276.584.1 328.6%  
Earnings per share (Unadj.) Rs-79.2-18.3 432.7%  
Cash flow per share (Unadj.) Rs-43.5-6.7 648.6%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs53.983.7 64.4%  
Shares outstanding (eoy) m70.4561.25 115.0%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.41.4 30.2%   
Avg P/E ratio x-1.4-6.3 22.9%  
P/CF ratio (eoy) x-2.6-17.2 15.3%  
Price / Book Value ratio x2.11.4 153.9%  
Dividend payout %00-   
Avg Mkt Cap Rs m8,0677,074 114.0%   
No. of employees `0002.82.8 101.8%   
Total wages/salary Rs m2,5271,449 174.4%   
Avg. sales/employee Rs Th6,956.11,874.1 371.2%   
Avg. wages/employee Rs Th902.5527.0 171.3%   
Avg. net profit/employee Rs Th-1,993.0-407.7 488.8%   
INCOME DATA
Net Sales Rs m19,4775,154 377.9%  
Other income Rs m407100 408.0%   
Total revenues Rs m19,8845,254 378.5%   
Gross profit Rs m1,103-766 -143.9%  
Depreciation Rs m2,519711 354.3%   
Interest Rs m5,2271,503 347.8%   
Profit before tax Rs m-6,236-2,881 216.5%   
Minority Interest Rs m2011 182.4%   
Prior Period Items Rs m0-6 0.0%   
Extraordinary Inc (Exp) Rs m5111,771 28.9%   
Tax Rs m-12517 -745.2%   
Profit after tax Rs m-5,580-1,121 497.7%  
Gross profit margin %5.7-14.9 -38.1%  
Effective tax rate %2.0-0.6 -344.2%   
Net profit margin %-28.7-21.8 131.7%  
BALANCE SHEET DATA
Current assets Rs m11,0143,810 289.1%   
Current liabilities Rs m32,0608,365 383.3%   
Net working cap to sales %-108.1-88.4 122.3%  
Current ratio x0.30.5 75.4%  
Inventory Days Days95156 60.9%  
Debtors Days Days3467 49.9%  
Net fixed assets Rs m29,44014,480 203.3%   
Share capital Rs m70561 1,149.3%   
"Free" reserves Rs m2,043903 226.2%   
Net worth Rs m3,8005,127 74.1%   
Long term debt Rs m9,0185,832 154.6%   
Total assets Rs m46,51019,433 239.3%  
Interest coverage x-0.2-0.9 21.1%   
Debt to equity ratio x2.41.1 208.6%  
Sales to assets ratio x0.40.3 157.9%   
Return on assets %-0.82.0 -38.7%  
Return on equity %-146.9-21.9 671.5%  
Return on capital %-3.73.6 -102.7%  
Exports to sales %37.924.5 154.5%   
Imports to sales %22.610.2 222.2%   
Exports (fob) Rs m7,3781,264 583.8%   
Imports (cif) Rs m4,406525 839.6%   
Fx inflow Rs m7,5131,539 488.1%   
Fx outflow Rs m5,649942 599.7%   
Net fx Rs m1,865597 312.2%   
CASH FLOW
From Operations Rs m1,682599 280.7%  
From Investments Rs m-9,860-438 2,251.7%  
From Financial Activity Rs m6,644-303 -2,195.6%  
Net Cashflow Rs m-1,535-141 1,086.3%  

Share Holding

Indian Promoters % 32.3 74.5 43.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.6 0.6 766.7%  
FIIs % 3.3 1.3 253.8%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 23.6 234.3%  
Shareholders   84,811 10,259 826.7%  
Pledged promoter(s) holding % 54.9 35.1 156.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   GLENMARK PHARMA  FULFORD INDIA  DR. REDDYS LAB  DIVIS LABORATORIES  UNICHEM LAB  

Compare ORCHID PHARMA LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Get Ready for Record Highs(Podcast)

Globally, Traders were left scrambling after the Federal Reserve forecast zero interest-rate hikes this year and just one in 2020.

Related Views on News

PANACEA BIOTECH Announces Quarterly Results (3QFY19); Net Profit Down 137.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, PANACEA BIOTECH has posted a net profit of Rs 230 m (down 137.1% YoY). Sales on the other hand came in at Rs 1 bn (down 25.2% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

PANACEA BIOTECH Announces Quarterly Results (2QFY19); Net Profit Down 1631.6% (Quarterly Result Update)

Nov 27, 2018 | Updated on Nov 27, 2018

For the quarter ended September 2018, PANACEA BIOTECH has posted a net profit of Rs 975 m (down 1631.6% YoY). Sales on the other hand came in at Rs 1 bn (down 22.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

PANACEA BIOTECH Announces Quarterly Results (4QFY18); Net Profit Down 66.5% (Quarterly Result Update)

Jun 20, 2018 | Updated on Jun 20, 2018

For the quarter ended March 2018, PANACEA BIOTECH has posted a net profit of Rs 86 m (down 66.5% YoY). Sales on the other hand came in at Rs 2 bn (up 0.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

More Views on News

Most Popular

My Top 3 Defence Stocks to Buy Now(The 5 Minute Wrapup)

Mar 19, 2019

The urgency to privatise India's defence sector to make India self-reliant was never as strong as it is today.

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

This Small Cap Stock Could Offer Triple Digit Gains from its Current Price(Profit Hunter)

Mar 19, 2019

If you are still waiting for signals, remember, there is no correct timing, only right time to Buy stocks. For select small caps, that time is now.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Mar 22, 2019 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 8-QTR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS